IRCT20210216050383N1招募中1 期
Evaluation of the therapeutic effect of pyridostigmine in post-stroke dysphagia
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with ischemic stroke revealed by CT scan or MRI 14 to 180 days before intervention
- •and diagnosed to have post-stroke dysphagia according to MASA score(more than 177) and PSR time(more than 1.5 s) assessed by a speech pathologist.
排除标准
- •Younger than 18
- •Hemorrhagic stroke
- •Stroke onset before 14 days or after 180 days
- •Head and/or neck injuries
研究者
相似试验
已完成
3 期
the effect of oral pyridostigmine on ileus after abdominal surgerypostoperative ileus (poi).Other postprocedural complications and disorders of digestive systemK91.89IRCT20180123038484N1Zahedan University of Medical Sciences40
招募中
1 期
Improving symptomatic treatment with pyridostigmine and amifampridine in patients with myasthenia gravisMedDRA version: 24.0Level: LLTClassification code 10085562Term: AChR myasthenia gravisSystem Organ Class: 100000004852Myasthenia GravisEUCTR2021-004110-20-NLeiden University Medical Center24
招募中
3 期
Improving symptomatic treatment with pyridostigmine and amifampridine: a randomized double-blinded, placebo controlled crossover trial in patients with myasthenia gravis (IMPACT-MG)Myasthenia GravisNL-OMON54093eids Universitair Medisch Centrum24
尚未招募
2 期
Efficacy of oral pyridostigmine for the treatment of acute colonic pseudo-obstruction - a prospective, randomized, placebo-controlled trial.ACTRN12621000254897Eastern Health - Box Hill Hospital40
尚未招募
4 期
Evaluation of the efficacy and safety of the drugs Pyronaridine-Artesunate (Pyramax™) and Primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Salavanh province, Lao PDRMalariaACTRN12618001348246Ministry of Health120